ADHD medication management covers stimulant medications (methylphenidate class, amphetamine class) and non-stimulants (atomoxetine, viloxazine, guanfacine ER, clonidine ER). Selection considers response history, cardiovascular status, substance-use history, and comorbid anxiety. Dr. Farkas titrates to response, monitors cardiovascular parameters, and coordinates with primary care.
↑ Medication classes & protocols
Frequently Asked Questions
Are stimulants safe long-term?
Stimulants have decades of safety data when appropriately prescribed and monitored. Cardiovascular baseline and periodic monitoring, screening for substance-use risk, and titration to therapeutic effect are standard. Long-term treatment is common and safe in appropriate patients.
What are the non-stimulant options?
Atomoxetine (a norepinephrine reuptake inhibitor), viloxazine ER, and alpha-2 agonists (guanfacine ER, clonidine ER). All are FDA-approved for ADHD. Non-stimulants are indicated when stimulants are contraindicated or when comorbid anxiety, tics, or substance-use history argue against stimulants.
Can I take stimulants with anxiety?
Sometimes. Stimulants can worsen anxiety in some patients; in others, treating ADHD reduces anxiety by improving function and reducing self-criticism. Careful titration and consideration of augmentation with an SSRI or non-stimulant strategy addresses comorbidity.
Related pages
ADHD Stimulant &
Non-Stimulant Medications
Stimulant and non-stimulant optimization for adult ADHD — matching the formulation, release profile, and dose to your specific presentation, schedule, and coexisting conditions. Adult ADHD is frequently undertreated; Dr. Farkas takes it seriously.
How Dr. Farkas approaches
Non-Stimulant Medications
Evidence-based, neurobiologically-informed. Every prescribing decision is grounded in mechanism — not tradition or trial-and-error.
From evaluation to
lasting results
ADHD Stimulants is used to treat
these conditions
Don't see your condition? View all 28 conditions treated →
What to expect at
your first appointment
New patient evaluations are 30–60 minutes — never a rushed intake. Dr. Farkas takes your full psychiatric, medical, and medication history before making any prescribing decisions. You'll leave with a clear diagnosis, a treatment plan that makes sense to you, and a follow-up already scheduled.
Telehealth available throughout South Carolina, New York, and Virginia. In-person at our Hilton Head Island, SC office.
Ready for prescribing done
at the MD/PhD level?
30–60 minutes. Expert diagnosis. A treatment plan built around your specific neurobiology and goals.